Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Rheumatoid arthritis

The two faces of Rsk2 in hyperplastic disease

Given the established role of 90 kDa ribosomal S6 kinases (Rsk) in oncogenesis, and the promise of new Rsk-blocking cancer treatments, it is perhaps surprising that Rsk2-mediated inhibition of hyperplasia has now been demonstrated to occur in the arthritic synovium. Does this functional duality make Rsk2 a risky target for the treatment of rheumatoid arthritis?

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: The function of Rsk proteins in oncogenesis and synovial hyperplasia.

References

  1. Yukinori, O. et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506, 376–381 (2014).

    Article  Google Scholar 

  2. Derer, A. et al. Rsk2 controls synovial fibroblast hyperplasia and the course of arthritis. Ann. Rheum. Dis. http://dx.doi.org/10.1136/annrheumdis-2014-205618.

  3. Facciponte, J. G. et al. Tumor endothelial marker 1–specific DNA vaccination targets tumor vasculature. J. Clin. Invest. 124, 1497–1511 (2014).

    Article  CAS  Google Scholar 

  4. Sherlock, J. P., Filer, A. D., Isaacs, J. D. & Buckley, C. D. What can rheumatologists learn from translational cancer therapy? Arthritis Res. Ther. 15, 114 (2013).

    Article  Google Scholar 

  5. Müller-Ladner, U. et al. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am. J. Pathol. 149, 1607–1615 (1996).

    PubMed  PubMed Central  Google Scholar 

  6. Lefèvre, S. et al. Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. Nat. Med. 15, 1414–1420 (2009).

    Article  Google Scholar 

  7. Firestein, G. S., Echeverri, F., Yeo, M., Zvaifler, N. J. & Green, D. R. Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc. Natl Acad. Sci. USA 94, 10895–10900 (1997).

    Article  CAS  Google Scholar 

  8. Böhm, C. et al. RSK2 protects against TNF-induced bone loss. J. Cell Sci. 125, 60–71 (2012).

    Article  Google Scholar 

  9. Lara, R., Seckl, M. J. & Pardo, O. E. The p90 RSK family members: common functions and isoform specificity. Cancer Res. 73, 5301–5308 (2013).

    Article  CAS  Google Scholar 

  10. Lee, D. M. et al. Cadherin-11 in synovial lining formation and pathology in arthritis. Science 315, 1006–1010 (2007).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christopher D. Buckley.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Falconer, J., Buckley, C. The two faces of Rsk2 in hyperplastic disease. Nat Rev Rheumatol 11, 203–205 (2015). https://doi.org/10.1038/nrrheum.2015.1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrrheum.2015.1

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer